WallStSmart
ROIV

Roivant Sciences Ltd

NASDAQ: ROIV · HEALTHCARE · BIOTECHNOLOGY

$28.56
+0.99% today

Updated 2026-05-08

Market cap
$20.24B
P/E ratio
P/S ratio
1,520.66x
EPS (TTM)
$-1.17
Dividend yield
52W range
$11 – $30
Volume
5.4M

WallStSmart proprietary scores

24
out of 100
Grade: F
Strong Sell
Investment rating
2.0
Growth
F
9.0
Quality
A+
2.5
Profitability
F
5.0
Valuation
C+
5/9
Piotroski F-Score
Moderate
12.9
Altman Z-Score
Safe zone
Industry rank
View all highly rated stocks (75+) →195 stocks currently score above 75

Price targets

Analyst target
$35.67
+24.89%
12-Month target
Intrinsic (DCF)
Margin of safety
2 Strong Buy10 Buy1 Hold0 Sell0 Strong Sell

Price chart

Stock snapshot

Strengths
+ Altman Z 12.89 — safe zone
+ Debt/equity 0.05x — low leverage
Risks
- Thin margins at 0.00%
- Negative free cash flow $-201.42M
- Revenue declining -77.80% QoQ

Key financials

Revenue Net Income Free Cash Flow
Metric2022202320242025TTM2026 (E)
Revenue$55.29M$61.28M$32.71M$29.05M$13.31M$0.0B
Net income$-845.26M$-1.01B$4.35B$-171.98M$-265.89M
EPS$-1.17$-1.23
Free cash flow$-695.16M$-856.08M$-766.65M$-844.05M$-201.42M
Profit margin-1,528.89%-1,646.59%13,294.18%-591.96%

Recent insider activity

DateInsiderTypeSharesPrice
2026-04-20VENKER, ERICSale200,000
2026-04-20VENKER, ERICBuy200,000$3.85
2026-04-20PULIK, RICHARDBuy84,026

Peer comparison

CompanyMkt CapScoreGrowthProfitValueQualityMoSRating
ROIV$20.24B242.02.55.09.0Avoid
LLY$869.41B7810.010.05.06.5Strong Buy
JNJ$535.63B594.79.03.36.0-38.45%Buy
ABBV$358.55B634.08.04.05.0-20.52%Buy
UNH$335.78B545.35.57.34.8+42.20%Buy
AZN$286.68B626.08.55.35.0+6.60%Buy

Smart narrative

Roivant Sciences Ltd trades at $28.56. Our Smart Value Score of 24/100 indicates the stock is weak. The company scores 5/9 on the Piotroski F-Score. With an Altman Z-Score of 12.89, it sits in the safe zone. TTM revenue stands at $13.31M.

Frequently asked questions

What is Roivant Sciences Ltd's stock price?
Roivant Sciences Ltd (ROIV) trades at $28.56.
Is Roivant Sciences Ltd overvalued?
Smart Value Score 24/100 (Grade F, Strong Sell).
What is the price target of Roivant Sciences Ltd (ROIV)?
The analyst target price is $35.67, representing +24.9% upside from the current price of $28.56.
What is the future stock price of ROIV by 2030?
Our research-backed model estimates Roivant Sciences Ltd could reach $22.30 by 2030, based on analyst consensus, management guidance, and sector analysis.
What is Roivant Sciences Ltd's revenue?
TTM revenue is $13.31M.
Piotroski F-Score?
5/9 — moderate financial health.
Altman Z-Score?
12.89 — safe zone.

Company info

SectorHEALTHCARE
IndustryBIOTECHNOLOGY
CountryUSA
ExchangeNASDAQ
CurrencyUSD

Quick metrics

P/S ratio1,520.66x
ROE-19.10%
Beta1.14
50D MA$28.33
200D MA$20.96
Shares out0.72B
Float0.53B
Short ratio
Avg volume5.4M

Performance

1 week+1.62%
1 month-0.70%
3 months+9.53%
YTD+30.32%
1 year
3 years
5 years